D L Straight - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D L Straight

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Archives of Biochemistry and Biophysics|May 1, 1985

Activation of normal and abnormal human factor IX with trypsinD M Monroe, C M Noyes, D L Straight, et al.

Biochemistry|February 4, 1999

Factor VIIa's first epidermal growth factor-like domain's role in catalytic activityJ Jin, J Chang, J Y Chang, et al.

The Journal of Biological Chemistry|June 20, 1998

Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activityJ Chang, J Jin, P Lollar, et al.

The Journal of Biological Chemistry|May 15, 1991

The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cellsW F Cheung, D L Straight, K J Smith, et al.

The Journal of Biological Chemistry|June 10, 1984

Bovine alpha- and beta-thrombin. Reduced fibrinogen-clotting activity of beta-thrombin is not a consequence of reduced affinity for fibrinogenR L Lundblad, M E Nesheim, D L Straight, et al.

The Journal of Biological Chemistry|March 10, 1985

Structural and functional characteristics of activated human factor IX after chemical modification of gamma-carboxyglutamic acid residuesD L Straight, G B Sherrill, C M Noyes, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Archives of Biochemistry and Biophysics|May 1, 1985

Activation of normal and abnormal human factor IX with trypsinD M Monroe, C M Noyes, D L Straight, et al.

Biochemistry|February 4, 1999

Factor VIIa's first epidermal growth factor-like domain's role in catalytic activityJ Jin, J Chang, J Y Chang, et al.

The Journal of Biological Chemistry|June 20, 1998

Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activityJ Chang, J Jin, P Lollar, et al.

The Journal of Biological Chemistry|May 15, 1991

The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cellsW F Cheung, D L Straight, K J Smith, et al.

The Journal of Biological Chemistry|June 10, 1984

Bovine alpha- and beta-thrombin. Reduced fibrinogen-clotting activity of beta-thrombin is not a consequence of reduced affinity for fibrinogenR L Lundblad, M E Nesheim, D L Straight, et al.

The Journal of Biological Chemistry|March 10, 1985

Structural and functional characteristics of activated human factor IX after chemical modification of gamma-carboxyglutamic acid residuesD L Straight, G B Sherrill, C M Noyes, et al.

Pageof 2